Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

FDA advisory committee recommends approval of drug combination for hepatitis C

May 6, 1998

Sagami presents new anti-H. pylori agents

May 6, 1998

YJA-20379, an H+/K+-ATPase inhibitor that inhibits H. pylori

May 1, 1998

Corvas/Schering-Plough HCV protease collaboration extended

May 1, 1998

Gastric prokinetic effects and safety of EM-574 in healthy subjects

April 30, 1998

Gastric prokinetic/antiemetic agents from Dainippon

April 28, 1998

Clinical trials of reformulated H-BIG completed

April 28, 1998

TAK-044 and its effects on liver injury and portal hypertension in rats

April 28, 1998

FDA advisory committee will meet to discuss Avakine NDA

April 28, 1998

Roberts acquires Pentasa marketing rights from HMR

April 27, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...